Table 4.
PegIFN +RBV+ AMA (n = 106) | IFN+RBV+AMA (n = 82) | |
Treatment discontinuation for any | 10 (9.4%) | 17 (20.7%) |
Reason1 | ||
Study drug noncompliance | 2 | 11 |
Demyelinizing neuropathy | 1 | |
Depression | 1 | 1 |
Erythema | 1 | |
Pulmonary fibrosis | 1 | |
Hyperthyroidism | 1 | |
Hyperthyroidism & Insomnia | 1 | |
Increased ALT | 1 | |
Leukopenia | 1 | 3 |
Dyspnoea, Cough, Pruritus | 1 | |
Unknown reason | 1 |
Fisher’s exact test: P = 0.036.